Retatrutide is a newly discovered molecule that shows promise as a treatment for type 2 diabetes. It functions as a agonist of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating https://lilycnxz592813.blogolenta.com/36121301/dulaglutide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes